According to the previous study42,44, anti-PD1 therapy is likely to target the interaction between PD-L1 on macrophages and PD-1 on CD8 + T cells because these two proteins are highly expressed in macrophages and CD8 + T cells, respectively, compared to other cell types in the tumor tissues. The gene discussed is CD8A; the disease is neoplasm.